OX219
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OX219, covering 2015-10-28 to 2015-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence [Phase 4]